Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 13Breast 10Plasma cell 6Genitourinary 6Lymphoid 3CNS 3Thoracic 2Other solid neoplasm 2Tumor-Agnostic 1Sarcoma 1Other hematologic neoplasm 1Gynecologic 1Classical hematology 1

Conditions

Venous Thromboembolism 1Thrombosis 1Neoplasms 1

Interventions

Cyclophosphamide 79fludarabine phosphate 75Busulfan 53Whole-Body Irradiation 51Mycophenolic Acid 50Cyclosporine 47Peripheral Blood Stem Cell Transplantation 46fludarabine 42Antilymphocyte Serum 37Melphalan 36Tacrolimus 35Filgrastim 30Cord Blood Stem Cell Transplantation 27Radiotherapy 23Methotrexate 22Cytarabine 22Methylprednisolone 19Granulocyte Colony-Stimulating Factor 18apixaban 17Thiotepa 17Dalteparin 13thymoglobulin 12Rivaroxaban 12Alemtuzumab 12eltrombopag 11ferric carboxymaltose 10Surveys and Questionnaires 10Etoposide 10Epoetin Alfa 10Cyclosporins 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Simvastatin × Classical hematology × Clear all
NCT02285738 2019-05-08

Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Completed
17 enrolled
Classical hematology

Neoplasms, Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡